PANAGORA ASSET MANAGEMENT INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 129 filers reported holding ANI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$525,443
-14.3%
9,050
-20.6%
0.00%
-25.0%
Q2 2023$613,231
+17.7%
11,392
-13.1%
0.00%
+33.3%
Q1 2023$520,928
-48.3%
13,115
-47.6%
0.00%
-57.1%
Q4 2022$1,006,876
+234.5%
25,028
+166.9%
0.01%
+250.0%
Q3 2022$301,000
+4916.7%
9,379
+5725.5%
0.00%
Q1 2021$6,000
+20.0%
1610.0%0.00%
Q4 2020$5,0000.0%1610.0%0.00%
Q3 2020$5,0000.0%1610.0%0.00%
Q2 2020$5,000
-28.6%
1610.0%0.00%
Q1 2020$7,000
-95.4%
161
-93.5%
0.00%
-100.0%
Q4 2019$153,000
-15.5%
2,4880.0%0.00%0.0%
Q3 2019$181,000
-11.7%
2,4880.0%0.00%0.0%
Q2 2019$205,000
-84.5%
2,488
-86.7%
0.00%
-83.3%
Q1 2019$1,324,000
+46.3%
18,767
-6.6%
0.01%
+50.0%
Q4 2018$905,000
-14.0%
20,101
+8.0%
0.00%0.0%
Q3 2018$1,052,000
+238.3%
18,606
+196.0%
0.00%
+300.0%
Q1 2017$311,000
-30.9%
6,286
-15.3%
0.00%
-50.0%
Q4 2016$450,000
-36.2%
7,425
-30.1%
0.00%
-33.3%
Q3 2016$705,000
+49.0%
10,624
+25.3%
0.00%
+50.0%
Q2 2016$473,000
+66.0%
8,4760.0%0.00%
+100.0%
Q1 2016$285,000
-34.8%
8,476
-12.5%
0.00%
-50.0%
Q4 2015$437,000
+30.4%
9,692
+14.3%
0.00%0.0%
Q3 2015$335,000
-39.3%
8,479
-4.7%
0.00%
-33.3%
Q2 2015$552,000
+150.9%
8,895
+153.1%
0.00%
+200.0%
Q1 2015$220,000
+41.9%
3,514
+27.5%
0.00%0.0%
Q4 2014$155,0002,7570.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders